Stay updated on CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.

Latest updates to the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page
- Check4 days agoChange DetectedThe page now displays a revision update: Revision: v3.3.4 replaces Revision: v3.3.3. This appears to be a site maintenance/versioning change with no impact on the study details, eligibility criteria, or results presented. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a Locations section with Missouri as a study site; removed the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check54 days agoChange DetectedThe revisions metadata now shows v3.3.2 instead of v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedThe government funding/operating status disclaimer was removed from the page.SummaryDifference0.3%

- Check76 days agoChange DetectedThe updates are administrative edits to the trial record, including the last update date, with no changes to core study information (design, endpoints, eligibility, or treatments). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check104 days agoChange DetectedMajor update includes a government operating status notice and a new version tag (v3.2.0); removal of a specific resource (Carcinoma of esophagus) from genetic resources.SummaryDifference3%

Stay in the know with updates to CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.